PuSH - Publikationsserver des Helmholtz Zentrums München

Zeitschriften-Browsing

98 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
▮◀ ◀◀ 1 ... 2 ... 3 ... 4 ... 5 ... ▶▶ ▶▮
Alle Publikationen dieser Seite in den Korb legen
21.
Modena, D.* et al.: Identification of a Novel SSTR3 full agonist for the treatment of nonfunctioning pituitary adenomas. Cancers 15:19 (2023)
22.
Spella, M. et al.: Non-oncogene addiction of KRAS-mutant cancers to IL-1β via versican and mononuclear IKKβ. Cancers 15:23 (2023)
23.
Starke, S.* et al.: Multitask learning with convolutional neural networks and vision transformers for outcome prediction of head and neck cancer patients Cancers 15:21 (2023)
24.
Strand, Z.* et al.: Establishment of a 3D model to characterize the radioresponse of patient-derived glioblastoma cells. Cancers 15:14 (2023)
25.
Waltenberger, M.* ; Strick, C.* ; Vogel, M.M.E.* ; Diehl, C. & Combs, S.E.: SBRT of spinal metastases using a simultaneous integrated boost concept in oligometastatic cancer patients is safe and effective. Cancers 15:5813 (2023)
26.
Zollner, L.* et al.: Gallbladder cancer risk and indigenous South American Mapuche ancestry : Instrumental variable analysis using ancestry-informative markers. Cancers 15:17 (2023)
27.
Blandino, A.* et al.: Identification of circulating lncRNAs associated with gallbladder cancer risk by tissue-based preselection, cis-eQTL validation, and analysis of association with genotype-based expression. Cancers 14:634 (2022)
28.
Dumont, M.* et al.: Uncovering the contribution of moderate-penetrance susceptibility genes to breast cancer by whole-exome sequencing and targeted enrichment sequencing of candidate genes in women of European ancestry. Cancers 14:3363 (2022)
29.
Erlmeier, F.* et al.: MALDI mass spectrometry imaging—prognostic pathways and metabolites for renal cell carcinomas. Cancers 14:1763 (2022)
30.
Gentschev, I.* et al.: Tumor colonization and therapy by Escherichia coli nissle 1917 strain in syngeneic tumor-bearing mice is strongly affected by the gut microbiome. Cancers 14:6033 (2022)
31.
Geppert, J. et al.: Aging aggravates cachexia in tumor-bearing mice. Cancers 14:90 (2022)
32.
Gulde, S. et al.: Combined targeting of pathogenetic mechanisms in pancreatic neuroendocrine tumors elicits synergistic antitumor effects. Cancers 14:5481 (2022)
33.
Hess J. et al.: Integration of p16/HPV DNA status with a 24-miRNA-defined molecular phenotype improves clinically relevant stratification of head and neck cancer patients. Cancers 14:3745 (2022)
34.
Junker, Y.* et al.: As easy as 1, 2, 3? How to determine CBCT frequency in adjuvant breast radiotherapy. Cancers 14:4164 (2022)
35.
Kraus, K.M. et al.: Treatment planning study for microbeam radiotherapy using clinical patient data. Cancers 14:685 (2022)
36.
Kraus, K.M. et al.: Pneumonitis after stereotactic thoracic radioimmunotherapy with checkpoint inhibitors: Exploration of the dose-volume-effect correlation. Cancers 14:2948 (2022)
37.
Küchler, M.* et al.: Outcome after radiotherapy for vestibular schwannomas (VS)-differences in tumor control, symptoms and quality of life after radiotherapy with photon versus proton therapy. Cancers 14:1916 (2022)
38.
Lopez-Millan, B.* et al.: The multi-kinase inhibitor EC-70124 is a promising candidate for the treatment of FLT3-ITD-positive acute myeloid leukemia. Cancers 14:1593 (2022)
39.
Lyu, C.* et al.: Identification of EZH2 as cancer stem cell marker in clear cell renal cell carcinoma and the anti-tumor effect of epigallocatechin-3-gallate (EGCG). Cancers 14:4200 (2022)
40.
Patil, S.* et al.: A novel 2-metagene signature to identify high-risk HNSCC patients amongst those who are clinically at intermediate risk and are treated with PORT. Cancers 14:3031 (2022)
▮◀ ◀◀ 1 ... 2 ... 3 ... 4 ... 5 ... ▶▶ ▶▮